S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
Why I Sued the Gov’t – And What I Recommend Now (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
Why I Sued the Gov’t – And What I Recommend Now (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
Why I Sued the Gov’t – And What I Recommend Now (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
5 Tips I Wish I Knew Before Starting My Business
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Live Updates: Russia-Ukraine War
Too Soon: 3 Reasons to Wait on DocuSign Stock
Why I Sued the Gov’t – And What I Recommend Now (Ad)
WTO predicts trade growth to slow next year amid crises
OPEC+ makes big oil cut to boost prices; pump costs may rise
Why I Sued the Gov’t – And What I Recommend Now (Ad)
Stocks slump as Wall Street’s big rally fades, yields rise
Rite-Aid Sings a Familiar Tune That Investors Don’t Want to Hear
NYSE:VAPO

Vapotherm - VAPO Stock Forecast, Price & News

$2.03
+0.06 (+3.05%)
(As of 10/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.91
$2.12
50-Day Range
$1.44
$2.56
52-Week Range
$1.39
$25.80
Volume
90,288 shs
Average Volume
269,506 shs
Market Capitalization
$54.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.75

Vapotherm MarketRank™ Forecast

Analyst Rating
Hold
1.80 Rating Score
Upside/​Downside
134.0% Upside
$4.75 Price Target
Short Interest
Healthy
1.59% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$67,000 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($2.87) to ($2.13) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.08 out of 5 stars

Medical Sector

518th out of 1,072 stocks

Surgical & Medical Instruments Industry

52nd out of 103 stocks

VAPO stock logo

About Vapotherm (NYSE:VAPO) Stock

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Receive VAPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vapotherm and its competitors with MarketBeat's FREE daily newsletter.

VAPO Stock News Headlines

5 Game-Changing Cheap Stocks
These 5 stocks have the potential to outperform the overall market over time because of their future potential. They are well-positioned to deliver a high upside to investors over the next 12 to 18 months. Discover all the details - including name and ticker symbol - here. pixel
Trade With Artificial Intelligence for Happiness
There are thousands of trading tools, but only one A.I. that has 2 patents for Predictive Technical Indicators and Intermarket Analysis. People desperately search for more security in their investments, and now is the best time to explore the precision and confidence boosting powers of A.I. Save your seat to register. pixel
Vapotherm: Q2 Earnings Snapshot
Where Vapotherm Stands With Analysts
See More Headlines
Receive VAPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vapotherm and its competitors with MarketBeat's FREE daily newsletter.

VAPO Company Calendar

Last Earnings
8/03/2022
Today
10/05/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
510
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.75
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
+134.0%
Consensus Rating
Hold
Rating Score (0-4)
1.80
Research Coverage
5 Analysts

Profitability

Net Income
$-59,800,000.00
Net Margins
-102.94%
Pretax Margin
-102.94%

Debt

Sales & Book Value

Annual Sales
$113.29 million
Book Value
$2.56 per share

Miscellaneous

Free Float
23,867,000
Market Cap
$54.19 million
Optionable
Not Optionable
Beta
-0.02

Key Executives

  • Mr. Joseph F. Army CPA (Age 58)
    CPA, CEO, Pres & Director
    Comp: $1.61M
  • Mr. John LandryMr. John Landry (Age 49)
    Sr. VP, CFO & Treasurer
    Comp: $772.21k
  • Mr. Gregoire RamadeMr. Gregoire Ramade (Age 52)
    Sr. VP & Chief Commercial Officer
    Comp: $936.74k
  • Mr. William Niland
    Founder
  • Ms. Dorota Mckay (Age 40)
    Chief Accounting Officer & Controller
  • Mr. Brian Lawrence (Age 52)
    Sr. VP & CTO
  • Mr. Anthony Ten Haagen
    VP of Legal & Compliance
  • Mr. James A. Lightman (Age 64)
    Sr. VP, Gen. Counsel & Sec.
  • Ms. Lindsay Becker (Age 37)
    VP of HR
  • Dr. Michael C. McQueen FAAP (Age 62)
    M.D., MBA, Sr. VP & Chief Medical Officer













VAPO Stock - Frequently Asked Questions

Should I buy or sell Vapotherm stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Vapotherm in the last year. There are currently 1 sell rating and 4 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" VAPO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VAPO, but not buy additional shares or sell existing shares.
View VAPO analyst ratings
or view top-rated stocks.

What is Vapotherm's stock price forecast for 2022?

5 equities research analysts have issued 12-month price targets for Vapotherm's stock. Their VAPO share price forecasts range from $2.00 to $7.00. On average, they expect the company's stock price to reach $4.75 in the next twelve months. This suggests a possible upside of 134.0% from the stock's current price.
View analysts price targets for VAPO
or view top-rated stocks among Wall Street analysts.

How have VAPO shares performed in 2022?

Vapotherm's stock was trading at $20.71 on January 1st, 2022. Since then, VAPO shares have decreased by 90.2% and is now trading at $2.03.
View the best growth stocks for 2022 here
.

When is Vapotherm's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our VAPO earnings forecast
.

How were Vapotherm's earnings last quarter?

Vapotherm, Inc. (NYSE:VAPO) announced its quarterly earnings data on Wednesday, August, 3rd. The company reported ($0.84) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.78) by $0.06. The business earned $12.97 million during the quarter, compared to analysts' expectations of $19.34 million. Vapotherm had a negative trailing twelve-month return on equity of 142.53% and a negative net margin of 102.94%.

What guidance has Vapotherm issued on next quarter's earnings?

Vapotherm updated its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $76.00 million-$81.00 million, compared to the consensus revenue estimate of $81.99 million.

What is Joe Army's approval rating as Vapotherm's CEO?

65 employees have rated Vapotherm Chief Executive Officer Joe Army on Glassdoor.com. Joe Army has an approval rating of 93% among the company's employees. This puts Joe Army in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Vapotherm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vapotherm investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Micron Technology (MU), Block (SQ), Taiwan Semiconductor Manufacturing (TSM), Synaptics (SYNA), VBI Vaccines (VBIV) and

When did Vapotherm IPO?

(VAPO) raised $60 million in an IPO on Wednesday, November 14th 2018. The company issued 4,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and William Blair acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Vapotherm's stock symbol?

Vapotherm trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAPO."

How do I buy shares of Vapotherm?

Shares of VAPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vapotherm's stock price today?

One share of VAPO stock can currently be purchased for approximately $2.03.

How much money does Vapotherm make?

Vapotherm (NYSE:VAPO) has a market capitalization of $54.19 million and generates $113.29 million in revenue each year. The company earns $-59,800,000.00 in net income (profit) each year or ($3.71) on an earnings per share basis.

How many employees does Vapotherm have?

The company employs 510 workers across the globe.

How can I contact Vapotherm?

Vapotherm's mailing address is 100 DOMAIN DRIVE, EXETER NH, 03833. The official website for the company is www.vapotherm.com. The company can be reached via phone at (866) 410-9986 or via email at ir@vtherm.com.

This page (NYSE:VAPO) was last updated on 10/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.